• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物特征的跨种族评估显示,北印度炎症性肠病队列中口腔致病共生菌的定植增加。

Cross-ethnic evaluation of gut microbial signatures reveal increased colonization with oral pathobionts in the north Indian inflammatory bowel disease cohort.

作者信息

Singh Arshdeep, Juyal Garima, Gacesa Ranko, Joshi Mohan C, Midha Vandana, Thelma B K, Weersma Rinse K, Sood Ajit

机构信息

Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India.

Department of Biotechnology, School of Engineering and Applied Sciences, Bennett University, Greater Noida, India.

出版信息

Intest Res. 2025 Jul 14. doi: 10.5217/ir.2024.00216.

DOI:10.5217/ir.2024.00216
PMID:40659339
Abstract

BACKGROUND/AIMS: Inflammatory bowel disease (IBD) has become a global health concern. With the growing evidence of the gut microbiota's role in IBD, studying microbial compositions across ethnic cohorts is essential to identify unique, populationspecific microbial signatures.

METHODS

We analyzed stool samples and clinical data from 254 IBD patients (226 ulcerative colitis, 28 Crohn's disease) and 66 controls in northern India using metagenomic shotgun sequencing to assess microbiota diversity, composition, and function. Results were replicated in 436 IBD patients and 903 controls from the Netherlands using identical workflows. Using machine learning, we evaluated the generalizability of Indian IBD signals to the Dutch cohort, and vice versa.

RESULTS

Indian IBD patients exhibited reduced bacterial diversity and an abundance of opportunistic pathogens, including Clostridium, Streptococcus, and oral bacteria like Streptococcus oralis and Bifidobacterium dentium. There was a significant loss of energy metabolic pathways and distinct co-occurrence patterns among microbial species. Notably, 39% of these signals replicated in the Dutch cohort. Unique to the Indian cohort were oral pathobionts such as Scardovia, Oribacterium, Actinomyces dentalis, and Klebsiella pneumoniae. Both Indian and Dutch IBD patients shared reduced butyrate producers. Machine-learning diagnostic models trained on the Indian cohort achieved high predictive accuracy (sensitivity 0.84, specificity 0.95) and moderately generalized to the Dutch cohort (sensitivity 0.77, specificity 0.69).

CONCLUSIONS

IBD patients across populations exhibit shared and unique microbial signatures, suggesting a role for the oral-gut microbiome axis in IBD. Crossethnic diagnostic models show promise for broader applications in identifying IBD.

摘要

背景/目的:炎症性肠病(IBD)已成为全球关注的健康问题。随着越来越多证据表明肠道微生物群在IBD中发挥作用,研究不同种族队列中的微生物组成对于识别独特的、特定人群的微生物特征至关重要。

方法

我们使用宏基因组鸟枪法测序分析了印度北部254例IBD患者(226例溃疡性结肠炎,28例克罗恩病)和66例对照的粪便样本及临床数据,以评估微生物群的多样性、组成和功能。使用相同的工作流程在来自荷兰的436例IBD患者和903例对照中重复了结果。我们使用机器学习评估了印度IBD信号对荷兰队列的可推广性,反之亦然。

结果

印度IBD患者的细菌多样性降低,机会性致病菌大量存在,包括梭菌属、链球菌属以及口腔细菌如口腔链球菌和龋齿双歧杆菌。能量代谢途径显著丧失,微生物物种之间存在明显的共现模式。值得注意的是,这些信号中有39%在荷兰队列中得到重复。印度队列特有的是口腔致病共生菌,如斯卡多维亚菌属、口腔杆菌属、齿放线菌和肺炎克雷伯菌。印度和荷兰的IBD患者都有丁酸产生菌减少的情况。在印度队列上训练的机器学习诊断模型具有较高的预测准确性(敏感性0.84,特异性0.95),并适度推广到荷兰队列(敏感性0.77,特异性0.69)。

结论

不同人群的IBD患者表现出共同和独特的微生物特征,表明口腔-肠道微生物群轴在IBD中发挥作用。跨种族诊断模型在识别IBD方面具有更广泛应用的潜力。

相似文献

1
Cross-ethnic evaluation of gut microbial signatures reveal increased colonization with oral pathobionts in the north Indian inflammatory bowel disease cohort.肠道微生物特征的跨种族评估显示,北印度炎症性肠病队列中口腔致病共生菌的定植增加。
Intest Res. 2025 Jul 14. doi: 10.5217/ir.2024.00216.
2
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测
J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.
3
[1]The human gut microbiota in IBD, characterizing hubs, the core microbiota and terminal nodes: a network-based approach.[1]炎症性肠病中的人体肠道微生物群,表征枢纽、核心微生物群和终端节点:一种基于网络的方法。
BMC Microbiol. 2025 Jun 26;25(1):371. doi: 10.1186/s12866-025-04106-0.
4
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
5
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
6
Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model.靶向微生物群和宿主炎性小体的抑制剂纳米低聚物在小鼠结肠炎模型中具有治疗作用。
ACS Pharmacol Transl Sci. 2024 Aug 30;7(9):2677-2693. doi: 10.1021/acsptsci.4c00102. eCollection 2024 Sep 13.
7
Vitamin D for the treatment of inflammatory bowel disease.维生素 D 治疗炎症性肠病。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2.
8
Composition and Function of the Gut Microbiome in Microscopic Colitis.显微镜下结肠炎中肠道微生物群的组成与功能
medRxiv. 2024 Oct 29:2024.10.28.24316293. doi: 10.1101/2024.10.28.24316293.
9
The Fecal Microbiome of IBD Patients Is Less Divertible by Bowel Preparation Compared to Healthy Controls: Results From a Prospective Study.与健康对照相比,炎症性肠病患者的粪便微生物群受肠道准备的影响较小:一项前瞻性研究的结果
Inflamm Bowel Dis. 2025 Jul 7;31(7):2007-2018. doi: 10.1093/ibd/izaf053.
10
The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab.使用英夫利昔单抗成功治疗炎症性肠病时,肠道黏膜和粪便中的细菌总量会增加。
Microbiol Spectr. 2025 Aug 5;13(8):e0189424. doi: 10.1128/spectrum.01894-24. Epub 2025 Jul 7.